Ligua Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,838M | ¥3,430M | ¥2,872M | ¥2,419M |
| Gross Profit | ¥1,225M | ¥1,879M | ¥1,706M | ¥1,423M |
| Operating Income | -¥508M | ¥118M | -¥155M | -¥123M |
| Pretax Income | -¥870M | ¥146M | -¥141M | -¥84M |
| Net Income | -¥774M | ¥104M | -¥301M | -¥241M |
| EPS | -¥552.13 | ¥71.17 | -¥202.46 | -¥159.28 |
| Operating Margin | -17.91% | 3.45% | -5.39% | -5.10% |
| Balance Sheet | ||||
| Total Assets | ¥3,374M | ¥3,869M | ¥3,142M | ¥2,493M |
| Total Equity | ¥353M | ¥605M | ¥320M | ¥177M |
| Total Liabilities | ¥3,021M | ¥3,264M | ¥2,822M | ¥2,316M |
| Cash | ¥1,173M | ¥1,327M | ¥1,352M | ¥1,187M |
| Interest-bearing Debt | ¥2,260M | ¥2,392M | ¥2,102M | ¥1,620M |
| Equity Ratio | 10.47% | 15.63% | 10.18% | 7.09% |
| D/E Ratio | 6.40 | 3.95 | 6.57 | 9.16 |
| Cash Flow | ||||
| Operating CF | -¥328M | ¥3M | ¥163M | ¥264M |
| Investing CF | -¥604M | ¥11M | ¥148M | -¥42M |
| Financing CF | ¥720M | ¥137M | -¥290M | -¥390M |
| Free CF | -¥468M | -¥20M | ¥127M | ¥254M |
| Efficiency | ||||
| ROE | -219.29% | 17.21% | -94.12% | -136.27% |
| ROA | -22.95% | 2.69% | -9.58% | -9.67% |
Latest IR Information
-
Q1 FY2027 Financial Results Summary (Consolidated) [Japanese GAAP]
Read more -
First Quarter Results Announcement for the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)
Read more -
Notice Regarding Recognition of Settlement Payments (Special Loss)
Read more -
Notice Regarding Receipt of Dividends from Consolidated Subsidiaries
Read more -
Notice Regarding the Disposal of Treasury Shares as Stock Incentives with Transfer Restrictions
Read more
Latest News (5 items)
Company Information
About
Ligua Inc., a consultancy company, engages in the provision of management support services in the healthcare industry. It operates through two segments: Orthopedic Clinic Solutions Business and Financial Services Business. The company offers orthopedic clinic software solutions, including Ligoo POS & CRM, a patient information management system for osteopathic clinics; and ReceONE, a receipt calculation system. It also provides orthopedic clinic equipment/consumables, such as EMS-indepth-, an electrical muscle stimulation device; Thomson bed, a hydraulically powered treatment table used to treat pain caused by pelvic or spinal misalignment; and Inject Energy, a low-frequency treatment device to treat pain and muscle atrophy. In addition, the company offers integrated functional mineral crystal technology products for blood circulation and balance under the Dr. Supporter, My. Supporter, and SLEEPINSTANT brands. Further, it provides educational training consulting services, including training programs and online customer attraction consulting services, as well as medical expenses billing agency services. Additionally, the company is involved in insurance agency and financial instruments intermediary activities, as well as provision of financial consulting services, such as mergers and acquisitions mediation. Ligua Inc. was incorporated in 2004 and is headquartered in Osaka, Japan.